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Abstract Chronic kidney disease is a major global health problem affecting millions of people; kidney tissue engineering
provides an opportunity to better understand this disease, and has the capacity to provide a cure. Two-dimensional cell
culture and decellularised tissue have been the main focus of this research thus far, but despite promising results these
methods are not without their shortcomings. Polymer fabrication techniques such as electrospinning have the potential to
provide a non-woven path for kidney tissue engineering. In this experiment we isolated rat primary kidney cells which were
seeded on electrospun poly(lactic acid) scaffolds. Our results showed that the scaffolds were capable of sustaining a multi-
population of kidney cells, determined by the presence of: aquaporin-1 (proximal tubules), aquaporin-2 (collecting ducts),
synaptopodin (glomerular epithelia) and von Willebrand factor (glomerular endothelia cells), viability of cells appeared to
be unaffected by fibre diameter. The ability of electrospun polymer scaffold to act as a conveyor for kidney cells makes
them an ideal candidate within kidney tissue engineering; the non-woven path provides benefits over decellularised tissue
by offering a high morphological control as well as providing superior mechanical properties with degradation over a
tuneable time frame.
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1 Introduction
Chronic kidney disease (CKD) is a major worldwide health
problem which attributes to 1.5% of deaths worldwide [1].
Current treatment involves dialysis and eventual trans-
plantation; dialysis is a costly technique which constrains
day to day life [2]. In 2016 there were 5275 people on the
transplant list in the UK alone [3], this places huge stresses
on health care providers as demand outstrips supply.
Recent strategies to overcome these shortcomings in
transplants are mainly focused on social policy with a new
system of presumed consent being proposed [4]. Additional
to this there are new avenues and endeavours in bioartifi-
cial kidney devices acting as miniaturised
implantable dialysis devices which are showing great
promise [5]. Furthermore, kidney tissue engineering is one
avenue that could provide a better basis for treatment and
understanding of CKD and has the unique potential to help
meet the ever-growing demand for organs.
Initial success in kidney tissue engineering have shown
potential as a testing platform for nephrotoxicity [6].
Current research has focused on simple microfluidic [7–11]
and co-culture [12, 13] models representing structures such
as the proximal tubules [7–9, 11] or glomerulus
[10, 12, 13]; other approaches have included the use of
embryonic or induced pluripotent cells cultured on tissue
culture plastic creating immature kidney organoids
[14–16]. A key element missing from these approaches is a
3D scaffold capable of providing mechanical strength,
architectural cues and structure.
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It is well documented that a 3D structure affects many
different cell types [17–20] and could quite possibly be a
crucial element of kidney tissue engineering. Decellu-
larised tissue is currently the predominant vehicle for 3D
kidney cell culture with impressive advances made
[21–24]. This involves flushing detergent through renal
tissue to wash out cells and DNA. This acellular extra-
cellular matrix (ECM) is then recellularized and in some
cases has been documented to produce rudimentary urine
[25]. However, the decellularisation of tissue is not a
simple process and the material left behind is often poorly
characterised and mechanically weak [21, 26, 27], added to
this the formidable task of recellularization [28] yielding
enough uncertainty that other avenues should be pursued
alongside.
Biomaterials such as polymer scaffolds have been
investigated for kidney tissue engineering in a limited
capacity, predominantly through investigation into hollow
fibre bioreactors [29] but also as a conduit for renal seg-
ments [30]. Synthetic polymers, such as PLGA, have also
been combined with natural ECM and have shown to
enhance biocompatibility and reduce hydrophobicity of
scaffolds compared to PLGA alone [31]. The paucity of
research in polymer scaffold for kidney tissue engineering
leave many avenues unexplored.
Electrospinning is a technique that has been utilised in
many areas of tissue engineering to yield non-woven fibres
resembling the ECM [32]. The technique produces con-
sistent scaffold properties that can be precise when envi-
ronmental parameters are finely controlled, including
humidity, temperature, polymer concentrations, voltage–
power, grounding and flow rate [33]. Morphologies of
electrospun scaffolds can also be controlled and can affect
how cells behave, larger fibres result in greater cell inte-
gration, nanofibers give a better representation of ECM and
aligned fibres can induce linear orientation of cells [34–36].
Techniques such as cryogenic electrospinning have also
demonstrated to increase the porosity of scaffolds allowing
for greater cell integration [37]. In kidney tissue engi-
neering electrospun collagen has been utilised to model the
glomerular capillary wall, with evidence of cell–cell
communication [13]. Electrospun polycaprolactone has
previously been used for culturing epithelial and endothe-
lial cell and shown to support cell life. Cells were seen to
migrate into scaffolds, an outcome which is highly desir-
able for a multi-cell population required to create an
organoid [38].
We have previously shown the ability of electrospun
scaffolds to support a kidney cell line [39]. Here, for the
first time to the authors knowledge, we study the growth of
a multipopulation of rat primary kidney cells on poly(lactic
acid) scaffolds of differing morphologies. With there being
a distinct lack of research into polymer scaffold for kidney
cells, here we show their intrinsic potential as a microen-
vironment that can maintain multiple cell phenotypic
characteristics.
2 Materials and methods
2.1 Electrospinning
Poly(lactic acid) (PLA) (Goodfellow, UK) was spun at 3
different percentage weight by volume solutions in
1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) (Manchester
Organics, UK). Small fibres were created from a 10% w/v
solution at ? 17, - 2 kV with a flow rate of 0.5 ml/h at a
needle to mandrel distance of 140 mm, needle bore of
0.4 mm. Medium fibres were created from an 18% w/v
solution at ? 15, - 4 kV with a flow rate of 4 ml/h at a
needle to mandrel distance of 200 mm, needle bore of
0.8 mm. Large fibres were created from a 22% w/v solu-
tion at ? 16, - 4 kV with a flow rate of 4 ml/h at a needle
to mandrel distance of 23 mm, needle bore 0.8 mm.
Cryogenic fibres were created using the same parameters
but with a mandrel filled with dry ice (- 78.5 C), topping
up with dry ice each hour. The low temperature causes ice
crystal deposition on the mandrel, increasing the porosity
of scaffolds. After spinning the mandrel is freeze dried for
24 h, leaving behind a cryogenically modified scaffold. All
fibres were spun at 250 rpm on to a mandrel covered in
aluminium foil with 16 ml of solution used for each scaf-
fold. Electrospun sheets were dried in a fume hood for 24 h
to remove residual solvent and cut into 10 mm disks ready
for cell seeding.
2.2 Mechanical testing
Mechanical testing was performed using an Instron 3367
(Instron, UK) tensile testing machine. A gauge length of
20 mm and width of 5 mm was used for test pieces and
thickness was measured using a digital micrometre. Sam-
ples were strained at 50% strain per minute with ultimate
tensile strength and incremental Young’s modulus (be-
tween 0 and 5% strain in 1% intervals) calculated from an
N C 5 independent replicates, as previously described
[40].
Estimated porosity was calculated by measuring the
density of the scaffold and dividing it by the known density
of PLA, as in the equation below:
Porosity ¼ 1 Density of Scaffold
Density of Polymer
 
 100
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2.3 Scanning electron microscopy
Fibres were coated using an Emscope SC500A splutter
coater using gold–palladium (60:40). A Hitachi S4700
fuelled emission scanning electron microscope (SEM)
(Hitachi) with a 5 kV accelerating voltage and a working
distance of 12 mm was used to image scaffolds.
2.4 Primary rat kidney isolation
Kidneys were taken from a 4-week-old female Sprague–
Dawley rat and washed in Krebs–Ringer bicarbonate buffer
supplemented with 1% antibiotic/antimycotic (anti/anti).
The renal capsule and adjacent connective tissue were
removed, and kidneys washed before placing in a falcon
tube containing Krebs–Ringer and anti/anti. Kidneys were
transferred to a cell culture hood and minced in a petri-dish
using a scalpel. Minced tissue was incubated in collagenase
from clostricium histolyticum (Sigma-Aldrich, UK) at a
concentration of 0.625 mg/ml for 30 min at 37 C, 2 kid-
neys per 12.5 ml. Following, the solution was filtered
through a 70 lm cell strainer and neutralised with Dul-
becco’s Modified Eagle’s Medium (DMEM) supplemented
with 1% anti/anti and 10% foetal bovine serum (FBS). The
solution was centrifuged at 500 g for 5 min and the
supernatant discarded. Cells were resuspended in a 1:1
ratio of DMEM and keratinocyte serum-free media
(KSFM) supplemented with 25 mg bovine pituitary extract
and 2.5 lg epidermal growth factor, 5% FBS and 1% anti/
anti. Cells were plated with 2 kidneys in 5 T175 flasks and
cultured for 24 h before washing with PBS and replen-
ishing media. Protocol adapted from He et al. [21] and
Joraku et al. [41].
2.5 Cell seeding
Scaffolds were sterilised in 2-propanol for 30 min before
washing 3 times in phosphate buffered saline (PBS).
Trypsin–EDTA 0.05% was used to lift cells from culture
flasks, neutralised in cell culture media and centrifuged at
500 g for 5 min. In 12 well suspension plates, 400,000
cells (p1) were seeded to each scaffold in 50 ll media and
left to attach for an hour before adding an additional 400 ll
media. Cultures were incubated at 37 C in 5% CO2 for 3
and 7 days and media was changed every 2 days.
2.6 Cell viability
A CellTitre-Blue assay (Promega, UK) was used to
evaluate cell viability. Scaffolds were placed in a new 48
well suspension plate and washed 3 times in PBS, 480 ll of
stock solution (5:1, media/assay) was added to each scaf-
fold and incubated for 2 h. Fluorescence was read using a
microplate reader (Modulus II 9300-062, Turner Biosys-
tems) at Ex 520 nm Em 580–640 nm, N = 4 independent
replicates. A standard curve was used to estimate cell
number.
2.7 DNA quantification
Scaffolds were washed 3 times in PBS and freeze dried for
24 h. Each scaffold was incubated within an ultrasonic bath
(6 litre Cavitek Digital, The Allendale Group, UK) in
300 ll of a 2.5 units/ml papain digest solution, 5 mM
cysteine HCL and 5 mM EDTA in PBS (all reagents from
Sigma Aldrich, UK) at 60 C for 24 h with periodic soni-
cation. Total DNA content of the samples was calculated
using a Quant-iTTM PicoGreen assay kit (ThermoFisher,
UK) as per the manufacturers’ instructions. Fluorescence
was read using a microplate reader at Ex 490 nm Em
510–570 nm, N = 4 independent replicates.
2.8 Immunohistochemistry imaging
Scaffold were washed 3 times in PBS and fixed in a 3.7%
(v/v) solution of formalin and PBS for 10 min, followed by
3 additional washes. Permeabilization was performed using
a 0.05% TWEEN in a 10 mM Tris and 1 mM MEDTA
solution, scaffolds were incubated in 300 ll for 1 h before
washing 3 times.
Scaffolds were dehydrated in 2-propanol solutions
graduating from 30 to 100% for 10 min in each. Scaffolds
were then left in a solution of 2-propanol and polyester wax
(1:1) at 50 C overnight. Next, scaffolds were placed in
polyester wax for 3 h and then fresh wax overnight at
50 C. Scaffold were halved and blocked for sectioning
into 35 lm slices.
Cell were stained for DNA using 0.1 mg/ml 40,6-di-
amidino-2-phenylindole (DAPI) (Sigma-Aldrich, UK) in
PBS for 10 min. IHC was performed to establish the
presence of key cell types including, primary antibodies
aquaporin-1, aquaporin-2 and synaptopodin (Stratech, UK)
were used at a 1 lg/ml dilution, von Willebrand factor
(Abcam, UK) was used at 2 lg/ml (Fig. 1), and scaffold
were incubated overnight in 10 ll, no-primary controls
were used. Alexa Fluor 488 anti-rabbit IgG (ThermoFisher,
UK) was used as a secondary antibody and left to incubate
for 1 h before performing 3 washes, 5 min each. Imaging
was done using a Zeiss Axio Imager fluorescence
microscope.
2.9 Statistical analysis
Data was tested using Levene’s test for equal variance
before statistical analysis was performed in order to select
appropriate tests. Electrospun fibre diameters were
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analysed using a one-way ANOVA with post hoc Games-
Howel test. CellTitre blue and mechanical data was anal-
ysed using a one-way ANOVA with post hoc Tukey pair-
wise comparison; as data had a slight positive skew it was
transformed by natural log giving a more normal distri-
bution. Data on electrospun fibres is presented as
mean ± standard deviation, all graphs are presented as
mean ± 95% confidence interval, circles on graphs denote
individual data points.
3 Results
3.1 Electrospun fibres
Non-woven fibres were created by electrospinning, it is
clear that the variation in spinning parameters produced
scaffolds of significantly different fibre diameters,
F(3,87) = 2274, p = 0 (Fig. 1). Discrepancies were found
between cryogenic and large fibre diameters, despite
spinning using the same parameters, which is as a result of
natural variation between spinning sessions and colder
spinning environment. Cryogenic electrospinning produced
a scaffold 5 times thicker than spinning with traditional
methods, this rise in thickness dramatically increases the
porosity from 82.5% for large fibres spun using the same
parameters to 97%, but it does come at the cost of
mechanical strength, Table 1.
The Young’s modulus at 0–5% strain was analysed by
one-way ANOVA, this analysis showed a significant dif-
ference between scaffolds F(3,21) = 103.32, p = 0,
Table 1. Post hoc analysis using Tukey test showed that all
scaffolds at 0–5% strain, except medium compared to large
fibres, were significantly different to each other, p\ 0.001.
Glomerular endothelia  
(Von Willebrand factor    ) 
DAPI 
Glomerular epithelia 
(Synaptopodin   ) 
Proximal tubules (Aquaporin-1    ) Collecting duct (Aquaporin-2    ) Fig. 1 A diagram of the kidney
showing the structure of kidney
including the nephron and
glomerulus, highlighting the
location of key cell types,
representative IHC images are
taken from large scaffold at
7 days, scale bar is 100 lm
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A similar trend follows with analysis of ultimate tensile
strength, F(3,21) = 133.31, p = 0. Post-hoc analysis
shows all scaffold are significantly different from each
other except large and medium scaffolds, p\ 0.05. Nota-
bly, randomly spun scaffolds reach a peak Young’s mod-
ulus at 2–3% strain whereas cryogenic spinning increases
the percentage strain at which Young’s modulus is highest
to 3–4% strain.
3.2 Cell viability and DNA quantification
CellTitre Blue, which was used to determine cell viabil-
ity, showed that cells did have a preference for a larger
fibre diameter however these differences were not signifi-
cant, the same applies to the number of viable cells from 3
to 7 days, F(7,24) = 2.05, p = 0.090. However, when
compared to cells grown on tissue culture plastic there
were significantly more cell present within the 12 well
plate control F(9,30) = 18.23, p = 0, with post hoc anal-
ysis showing significantly more cells on tissue culture
plastic than all scaffolds, Fig. 2.
Analysis of DNA quantification, determined by Pico-
Green assay, using a one-way ANOVA showed a signifi-
cant difference between groups, F(7,23) = 4.79,
p = 0.002. Post-hoc Tukey test highlighted that cryogenic
scaffolds at day 3 was significantly different from all
groups except cryogenic at day 7 and medium at day 3, no
other significant differences were seen. DNA quantification
validates the fact that the number of cells is does not
increase from 3 to 7 days, Fig. 3.
3.3 Immunohistochemistry
Immunohistochemistry (IHC) showed the presence of key
signatures of several cell types: aquaporin 1 and 2 showed
the presence of tubular cells, synaptopodin highlights
glomerular epithelial cells and von Willebrand factor
indicates glomerular endothelial cells. As seen in Fig. 4,
these key markers are seen on all scaffold types, demon-
strating the presence of a multi-population of cells. The
sectioned scaffold show that cells were seen throughout
cryogenic scaffolds, but less cell penetration was present
on all other fibres types.
4 Discussion
Emphasis so far in kidney tissue engineering has been on
2D cell culture, which has shown considerable progression
in recent years [15, 42, 43]. However, cells within the
Kidney do not exist within the two dimensional axis of cell
culture plastic, with greater amounts of research underlin-
ing the importance of a 3D structure [17, 44]. 3D kidney
tissue engineering has focused on the use of decellularised
tissue with promising results [25, 45]; this method is not
without its shortcomings, with issues surrounding decon-
tamination [46] and a lack of a standardized approach to
decellularisation leading to a variation between scaffolds
[21, 26, 27]. Decellularised tissue brings favourable phys-
ical and chemical characteristics to help support cells and
control physiology [47], but as cell produce their own ECM
a synthetic scaffold can provide an excellent foundation to
build upon [48, 49]. Polymer scaffolds offer many benefits
over decellularised tissue as their manufacture can be
highly controlled, as well as providing superior mechanical
properties with degradation over a tuneable time frame
[31, 33, 50].
Our electrospun fibres demonstrate the control with
which polymer scaffold are fabricated having a standard
deviation in fibre diameter and Young’s modulus (0–5%
strain) of less than 20% in all cases, Table 1. The increase
in porosity of 97.3% gained from cryogenic electrospin-
ning, demonstrated in the dramatic increase in thickness of
the scaffold spun under the same conditions as large fibres,
Table 1 Mechanical properties and physical properties of PLA scaffolds
Average Strain Small Medium Cryogenic Large
Fibre diameter, lm - 0.88 ± 0.16 2.46 ± 0.43 3.71 ± 0.36 3.30 ± 0.17
Scaffold thickness, lm - 193 ± 5.16 270 ± 8.63 1375 ± 160 218 ± 13.0
Porosity, % - 86.9 82.8 97.3 82.5
Young’s modulus at % Strain, MPa 0–1% 2.84 ± 1.41 5.78 ± 1.51 0.57 ± 0.15 7.15 ± 1.97
1–2% 6.53 ± 0.85 6.40 ± 1.49 0.72 ± 0.16 6.61 ± 0.81
2–3% 5.34 ± 0.91 9.13 ± 1.12 1.13 ± 0.30 8.69 ± 1.48
3–4% 4.76 ± 0.54 7.48 ± 0.94 1.31 ± 0.21 6.87 ± 1.62
4–5% 2.84 ± 0.67 4.22 ± 0.62 0.81 ± 0.14 3.59 ± 1.13
0–5% 5.05 ± 0.52 7.31 ± 0.84 1.01 ± 0.20 7.14 ± 1.04
Ultimate tensile strength, MPa 3.25 ± 0.21 4.25 ± 0.31 0.87 ± 0.17 4.02 ± 0.56
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comes at the cost of mechanical strength; fibres had an
UTS 5 times lower despite spinning under the same
parameters, this follows a similar trend to previous works
[37, 51]. The variation seen in scaffold thickness may be
influenced by a decrease in humidity due to the low tem-
perature as humidity is known to effect the diameter of
electrospun fibres [52], the low temperature of the mandrel
may also reduce the ambient temperature increasing the
viscosity of the polymer solution [53]. Interestingly,
Young’s modulus peaks in normally spun scaffolds at
2–3% strain but at 3–4% for cryogenically spun fibres this
is probably due the nature of the scaffold and looser
packing in cryogenic fibres allowing for more strain in the
scaffold before all fibres are in tension. Cryogenic scaffold
can be controlled further thought monitoring the humidity
of spinning conditions [54].
There is great scope for the use of polymer scaffolds
within kidney tissue engineering. Our work follows on
from the limited published research into the use of kidney
cells with electrospun scaffolds [13, 30, 55]. We have
previously shown that electrospun PCL can be used to
grow a kidney cells line, and highlighted the effects of
morphological differences in scaffolds [39]. Here we have
gone further, using RPK cells and demonstrating the sur-
vival of key cell types of this multi-cell population, Fig. 4.
Although, our results regarding fibre diameter and its
influence on cell behaviour are not conclusive, it has been
shown to have major implication in previous studies
[39, 56–58]. There is some disparity between our data for
CellTitre blue and DNA quantification, this is possibly as a
result of the much greater porosity gained from cryogenic
electrospinning where unattached cells become trapped
within the scaffold. It does however show that viable cells,
shown through CellTitre blue, are surviving over time as
DNA content remained constant.
An important factor to consider here is scaffold chem-
istry, we have demonstrated that PLA facilitates primary
cell survival but it is not optimised for kidney cells. Sur-
vival on polymer scaffold could be vastly improved with
optimisation through such techniques as microarray
[59–61] allowing for analysis of cell interaction with many
polymer types in a high-throughput manner. Other popular
optimisation techniques include integrating ECM compo-
nents with polymer scaffold to produce a hybrid deriving
Fig. 2 Scaffolds were fabricated by electrospinning, where a high
voltage is applied to a polymer solution, forming a Taylor cone, this is
then accelerated towards a ground source. Fibre architecture was
determined by spinning parameters; A cryogenic fibres, using ice
crystal formation as a template for fibre deposition and B random
fibres onto a slowly rotating mandrel. SEM images below demon-
strate the difference in fibre diameter of the scaffolds, which were
spun using the same solvent and polymer but different electrospinning
parameters and percentage weight solutions
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Fig. 3 Cell number estimated from a standard curve, analysed using
a CellTitre blue fluorescence assay. This demonstrates the ability of
all scaffold architectures to support primary kidney cell life. No
significant differences found in analysis using a one-way ANOVA
F(7,24) = 2.05, p = 0.090. Data presented as mean ± 95% confi-
dence intervals, circles show individual data points
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Fig. 4 DNA quantity per scaffold at 3 and 7 days, assessed by
PicoGreen assay. This confirms the ability of all scaffold architectures
to support primary kidney cell life. Analysis using a one-way
ANOVA showed significant differences F(7,23) = 4.79, p = 0.002,
post hoc Tukey analysis shows that was in regards to cryogenic
scaffolds. Data presented as mean ± 95% confidence intervals,
circles denote individual data points
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Glomerular endothelia (Von Willebrand factor)
Glomerular epithelia (Synaptopodin)
7
Days
3
Days
7
Days
3
Days
Large Medium Cryogenic Small
Proximal tubules (Aquaporin-1)
Collecting duct (Aquaporin-2)
7
Days
3
Days
7
Days
3
Days
A
D
B
C
Fig. 5 Fluorescence images
showing DAPI and IHC, used to
show the presence of key
functional marker of several cell
types: A–D aquaporin-2,
aquaporin-1 indicate the
presence of tubular cells, von
Willebrand factor indicates
glomerular endothelial cells and
synaptopodin indicated the
glomerular epithelia, scale bar is
100 lm
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benefits from both, this method has shown to improve the
mechanical properties of the scaffold whilst increasing cell
interaction [31]. Further novel techniques have used a
sacrificial cell layer to produce an ECM layer on top of the
polymer scaffold before decellularisation, maintaining the
initial mechanical characteristics [49]. Some of these
methods may bring about a greater interaction between
cells and scaffold and could provide more conclusive evi-
dence on the type of architecture that is most favourable to
kidney cells.
Fluorescence IHC images (Fig. 5) clearly shows the
presence of key markers of essential kidney cells (Fig. 1).
The marker which identified key cells were: aquaporin-1,
aquaporin 2, Synaptopodin and von Willebrand factor,
between them these highlight the cells which make up the
proximal tubules, collecting duct, glomerular epithelia and
glomerular endothelia, Fig. 1. The proximal tubules lead
from the loop of Henle and are responsible for the reuptake
of filtrate, they consist of epithelial cells with microvilli to
increase surface area [7]. The collecting duct is the last
stage of filtration where the filtrate is reabsorbed and col-
lected. The glomerular epithelia are more commonly
referred to as podocytes and form part of the glomerulus,
playing a key role in blood filtration through slits which
block the passage of larger molecules [62]. The glomerular
endothelium are another key component of the glomerular
characterised by fenestrations which are essential for fil-
tration [63]. In order for any kidney tissue engineering
scaffold intended to host a multi-cell population to be
considered successful it is essential to show the survival of
these key components; as can clearly be seen on our
scaffolds cells were displaying initial integration with the
3D structure. The sectioned scaffolds did not fully integrate
through the full depth in traditionally spun scaffolds, this is
a common problem with electrospun fibres, reported in
other works [64, 65]. Pore size of the scaffold is the pre-
dominant factor which limits cell infiltration, naturally the
larger the fibre the larger the pore size; methods such as co-
spinning of micro and nanofibres has been used to increase
this pore space [33, 66], as well as using a sacrificial dis-
solvable polymer in a similar co-spinning manner [67].
Here we demonstrate the use of cryogenic spinning
[51, 54], utilising ice crystals as a template the pore size is
dramatically increased. Although our results on the most
favourable morphology were inconclusive, we have
demonstrated the greater cell integration cryogenic scaffold
can bring, and have shown the potential of electrospun
PLA as a scaffold for rat primary kidney cells and its
capacity to maintain the multi-population of cells.
We did not see organisation of cells into kidney like
structures and more research is needed over a longer time
frame to assess for elements of self-organisation. The
ability of embryonic and induced pluripotent stem cells to
self-organise is well documented [6, 68], and these cells of
greater physiological and clinical relevance are the next
logical step for polymer scaffolds in kidney tissue engi-
neering. Our view is that polymer scaffolds have the ability
to act as a conveyor for kidney cells, allowing kidney cells
to self-organise before implantation where a full organ can
mature. We feel this is a reasonable alternative to the
implantation of decellularised organs, and has previously
been highlighted as a potential avenue [69].
We have demonstrated here the variation of architec-
tures that can be created from a single polymer and solvent
solution by electrospinning. This is just one polymer in
many that could be used in kidney tissue engineering.
Electrospun polymer scaffolds have the ability to create a
range of different architectures and should be considered
for further investigation in kidney tissue engineering due to
their: ability to host a multi-population of cells, biocom-
patibility, reproducibility, good mechanical properties and
3D structure. This is a new non-woven path within kidney
tissue engineering and one that should be explored further.
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